Kolexia
Lupo Julien
Pharmacien
Hôpital Nord Grenoble
La Tronche, France
69 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à virus Epstein-Barr COVID-19 Lymphomes Maladie de Hodgkin Infections à cytomégalovirus Infections à VIH Hépatite Syndromes lymphoprolifératifs Mélanome

Industries

Roche
5 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Epstein-Barr Virus Encephalitis: A Review of Case Reports from the Last 25 Years.
Microorganisms   21 novembre 2023
Unexpectedly long persistence of anti-SARS-CoV-2 spike monoclonal antibodies tixagevimab and cilgavimab in immunocompromised patients.
Transplant infectious disease : an official journal of the Transplantation Society   04 octobre 2023
Reflex testing automatization for HBsAg carriers: A novel era for hepatitis delta management.
JHEP reports : innovation in hepatology   10 juin 2023
Fatal HSV-2 primary infection most likely acquired by kidney transplantation: A case report.
International journal of antimicrobial agents   03 mars 2023
Virological Markers in Epstein-Barr Virus-Associated Diseases.
Viruses   28 février 2023
Comparison of Elecsys and Liaison immunoassays to determine Epstein-Barr virus serological status using further diagnostic approaches to clarify discrepant results.
Journal of medical virology   01 octobre 2022
Use of RT-PCR thermocycling program for the quantification of DNA viruses in a single run with RNA viruses: Example of Altona RealStar® HSV or VZV PCR kits.
Infectious diseases now   13 septembre 2022
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Vaccine   06 septembre 2022
High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD.
Pathogens (Basel, Switzerland)   17 août 2022
Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
Nucleic acids research   21 février 2022